Athira Pharma (ATHA) agreed to pay $4,068,698 to resolve allegations that it violated the False Claims Act by failing to report allegations of research misconduct to the National Institutes of ...

Bothell-based biopharmaceutical company Athira Pharma Inc. (Nasdaq: ATHA) is paying a $4.1 million fine due to allegations it used doctored research to land a National Institutes of Health grant.

From what we can see, insiders were net buyers in Athira Pharma, Inc.'s ( NASDAQ:ATHA ) during the past 12 months. That... BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma ...

Robert Renninger, the Vice President of Finance at Athira Pharma, Inc. (NASDAQ:ATHA), recently executed several transactions involving the company's stock, according to a filing with the ...